Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis

被引：0

作者：

Guttman-Yassky, Emma ^{[1
]}

Weidinger, Stephan ^{[2
]}

Simpson, Eric ^{[3
]}

Gooderham, Melinda ^{[4
,5
]}

Irvine, Alan ^{[6
]}

Spelman, Lynda ^{[7
,8
]}

Silverberg, Jonathan ^{[9
]}

Elmaraghy, Hany ^{[10
]}

DeLuca-Carter, Louise ^{[10
]}

Piruzeli, Maria Lucia Buziqui ^{[10
]}

Hu, Chaoran ^{[10
]}

Yang, Fan Emily ^{[10
]}

Pierce, Evangeline ^{[10
]}

Bardolet, Laia ^{[11
]}

Thaci, Diamant ^{[12
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Univ Hosp Schleswig Holstein, Kiel, Germany

[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[4] Prob Med Res, SKiN Dermatol, Peterborough, ON, Canada

[5] Queens Univ, Peterborough, ON, Canada

[6] Childrens Hlth Ireland, Dublin, Ireland

[7] Verac Clin Res, Woolloongabba, Qld, Australia

[8] Prob Med Res, Woolloongabba, Qld, Australia

[9] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA

[10] Eli Lilly & Co, Indianapolis, IN 46285 USA

[11] Almirall SA, Barcelona, Spain

[12] Univ Lubeck, Inst & Comprehens Ctr Inflammatory Med, Lubeck, Germany

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷

关键词：

atopic dermatitis; efficacy; lebrikizumab; phase; 3; trials; safety;

D O I：

10.1093/bjd/ljad498.005

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

494

引用

页码：II3 / II4

页数：2

共 50 条

[41] Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis
Paller, Amy S.
Eichenfield, Lawrence F.
Irvine, Alan D.
Flohr, Carsten
Wollenberg, Andreas
Barbarot, Sebastien
Bangert, Christine
Spergel, Jonathan M.
Selfridge, Andrew
Biswas, Pinaki
Fan, Haiyun
Alderfer, Justine
Watkins, Melissa
Koppensteiner, Herwig
ALLERGY, 2025,
[42] Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 3, Randomized, Placebo-Controlled Trial (ADhere)
Simpson, Eric L.
Gooderham, Melinda
Wollenberg, Andreas
Weidinger, Stephan
Armstrong, April
Soung, Jennifer
Ferrucci, Silvia
Lima, Renata Gontijo
Xu, Wen
Witte, Michael M.
Blauvelt, Andrew
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 61 - 61
[43] Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
Roekevisch, Evelien
Spuls, Phyllis Ira
Kuester, Denise
Limpens, Jacqueline
Schmitt, Jochen
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : 429 - 438
[44] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
Zhao, Dan-Jie
Li, Xia
Lin, Hai-Xia
Zheng, Hong
Zhou, Di
Tang, Peng
PLOS ONE, 2024, 19 (07):
[45] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
Meher, Bikash R.
Mishra, Archana
Behera, Biswanath
Ponnusamy, Subashri
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
[46] Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
Dupuis, Josephine
Tauber, Marie
Mahe, Emmanuel
Jachiet, Marie
Soria, Angele
Tetart, Florence
Puzenat, Eve
Pasteur, Justine
Raison-Peyron, Nadia
Giordano-Labadie, Francoise
Droitcourt, Catherine
Leleu, Camille
Nosbaum, Audrey
Aubert, Helene
Moigne, Marie L. E.
Bernier, Claire
Barbarot, Sebastien
Ezzedine, Khaled
Diaz, Emmanuelle
Hubiche, Thomas
Faiz, Sarah
Azib, Selma
Dezoteux, Frederic
Chosidow, Olivier
Staumont-Salle, Delphine
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e174 - e178
[47] Efficacy and safety of lebrikizumab in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis: a phase III randomized, placebo-controlled trial (ADhere)
Simpson, Eric L.
Gooderham, Melinda
Wollenberg, Andreas
Weidinger, Stephan
Armstrong, April
Soung, Jennifer
Ferrucci, Silvia
Lima, Renata Gontijo
Xu, Wen
Witte, Michael M.
Blauvelt, Andrew
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E108 - E108
[48] Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Silverberg, Jonathan I.
Bieber, Thomas
Paller, Amy S.
Beck, Lisa
Kamata, Masahiro
Puig, Luis
Wiseman, Marni
Ezzedine, Khaled
Irvine, Alan D.
Foley, Peter
Del Rosso, James
Gold, Linda Stein
Johansson, Erin
Dossenbach, Martin
Gallo, Gaia
Akmaz, Buelent
Casillas, Marta
Karlsson, Andrei
Curteis, Tristan
Chovatiya, Raj
DERMATOLOGY AND THERAPY, 2025, 15 (03) : 615 - 633
[49] LEBRIKIZUMAB MONOTHERAPY REDUCES FLARES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Del Rosso, James Q.
Kwong, Pearl
Hussain, Iftikhar
Barbarot, Sebastien
Manuel Carrascosa, Jose
Rueda, Maria Jose
Atwater, Amber Reck
Elmaraghy, Hany
Sun, Luna
Chen, Sherry
Natalie, Chitra R.
Weidinger, Stephan
ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 32
[50] Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trials
Silverberg, Jonathan
Thaci, Diamant
Seneschal, Julien
Gold, Linda Stein
Blauvelt, Andrew
Simpson, Eric
Chu, Chia-Yu
Liu, Zhuqing
Lima, Renata Gontijo
Pillai, Sreekumar
Guttman-Yassky, Emma
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 62 - 62

← 1 2 3 4 5 →